Health supervision for children with sickle cell disease

Pediatrics

Volumn 109, Issue 3, 2002, Pages 526-535

  Lane, Peter A ^a   Buchanan, George R ^a   Desposito, Franklin ^a   Pegelow, Charles H ^a   Vichinsky, Elliott P ^a   Wethers, Doris L ^a   Woods, Gerald M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

APLASTIC ANEMIA; CHILD; CLINICAL FEATURE; FAMILY; FEVER; GENETIC COUNSELING; HEALTH SERVICE; HUMAN; NEWBORN SCREENING; PAIN; PATIENT EDUCATION; PATIENT MONITORING; PRIAPISM; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REVIEW; SICKLE CELL ANEMIA;

EID: 0036181101     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.109.3.526     Document Type: Review

References (63)

1. Newborn screening for sickle cell disease: Effect on mortality
2. Comprehensive care in sickle cell disease: Its impact on morbidity and mortality
3. Polysaccharide encapsulated bacterial infection in sickle cell anemia: A thirty year epidemiologic experience
4. Improved survival in homozygous sickle cell disease: Lessons from a cohort study
5. Sickle cell disease
6. Sickle cell disease
7. Clinical events in the first decade in a cohort of infants with sickle cell disease
8. Mortality in sickle cell disease: Life expectancy and risk factors for early death
9. Prediction of adverse outcomes in children with sickle cell disease
10. Pain in sickle cell disease: Rates and risk factors
11. Serving, the family from birth to the medical home. Newborn screening: A blueprint for the future - A call for a national agenda on state newborn screening programs
12. US newborn screening system guidelines II: Follow-up of children, diagnosis, management, and evaluation
13. Sickle-cell disease not identified by newborn screening because of prior transfusion
14. Recommendations for preventive pediatric health care
15. Prophylaxis with oral penicillin in children with sickle cell anemia: A randomized trial
16. Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis
17. Discontinuing penicillin prophylaxis in children with sickle cell anemia
18. +-thalassemia: Is prophylactic penicillin necessary?
19. Plasma homocysteine levels and folate status in children with sickle cell anemia
20. Recommended childhood immunization schedule-United States, 2002
21. Technical report: Prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis
22. Natural history of blood pressure in sickle cell disease: Risks for stroke and death associated with relative hypertension in sickle cell anemia
23. Transfusion-related iron overload in sickle cell anemia
24. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions
25. Effects of a long-term transfusion regimen on sickle cell-related illnesses
26. Transfusion and alloimmunization in sickle cell disease
27. Experience with donors matched for donor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy
28. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease
29. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy
30. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease
31. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
32. Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study, a phase I/II trial
33. Impact of bone marrow transplantation for symptomatic sickle cell disease: An interim report
34. Bone marrow transplantation for sickle cell disease: Where do we go from here?
35. A possible disparity between standard of care and delivery of care in sickle cell disease, as assessed from sickle cell centers
36. Emergency preparedness for children with special health care needs
37. Bacteremia in sickle hemoglobinopathies
38. A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell disease
39. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States
40. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases
41. The acute chest syndrome of sickle cell disease
42. Causes and outcomes of the acute chest syndrome in sickle cell disease
43. Acute multi-organ failure syndrome. A potentially catastrophic complication of severe sickle cell pain episodes
44. A comparison of conservative and aggressive transfusion regimens in the preoperative management of sickle cell disease
45. Effect of transfusion in acute chest syndrome of sickle cell disease
46. Stroke in sickle cell disease: Demographic, clinical, and therapeutic considerations
47. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease
48. Long-term stroke risk in children with sickle cell disease screened with transcranial doppler
49. Prevention of first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography
50. Prevalence of priapism in children and adolescents with sickle cell anemia
51. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism
52. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease: A randomized cooperative study
53. Pregnancy in sickle cell disease: Experience of the cooperative study of sickle cell disease
54. 1994-1995 MMWR, prevention reptile-associated salmonellosis-selected states
55. Transition of care provided for adolescents with special health care needs